Ann Beaumont
Impact in
-
- Neuropeptides and Animal Physiology
- Oncology top 5%
- Peptidase Inhibition and Analysis
Papers in
-
- Neuropeptides and Animal Physiology 23
-
- Signaling Pathways in Disease 7
- Biochemical and Structural Characterization 6
- Receptor Mechanisms and Signaling 5
- Co-authors
- B P Roques (6 shared papers)M C Fournié-Zaluski (3 shared papers)Florence Noble (1 shared paper)V. Daugé (1 shared paper)Bernárd P. Roques (10 shared papers)Joel W. Hughes (4 shared papers)Michael O’Donohue (4 shared papers)Cynthia Marie‐Claire (4 shared papers)
- Journals
- Journal of Biological Chemistry (5 papers)Biochemical and Biophysical Research Communications (3 papers)FEBS Letters (2 papers)Molecular Pharmacology (2 papers)Biochemical Pharmacology (2 papers)
- Partner nations
- FranceUnited KingdomCanada
In The Last Decade
Ann Beaumont
39 papers receiving 1.8k citations
Ann Beaumont's Hit Papers
Peers
Comparison fields: 5 of 103
- Cellular and Molecular Neuroscience 848
- Oncology 813
- Molecular Biology 956
- Physiology 322
- Biotechnology 90
Countries citing papers authored by Ann Beaumont
This map shows the geographic impact of Ann Beaumont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Beaumont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Beaumont more than expected).
Fields of papers citing papers by Ann Beaumont
This network shows the impact of papers produced by Ann Beaumont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Beaumont. The network helps show where Ann Beaumont may publish in the future.
Co-authors
The 25 scholars most cited alongside Ann Beaumont, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Hit paper breakdown → | 1993 | 647 |
| 2 | 1987 | 199 | |
| 3 | 1979 | 141 | |
| 4 | 1998 | 84 | |
| 5 | 1990 | 80 | |
| 6 | 1988 | 75 | |
| 7 | 1995 | 60 | |
| 8 | 1991 | 56 | |
| 9 | 1999 | 52 | |
| 10 | 1992 | 52 | |
| 11 | 1996 | 49 | |
| 12 | 1994 | 38 | |
| 13 | 1998 | 36 | |
| 14 | 1987 | 32 | |
| 15 | 1997 | 32 | |
| 16 | 1992 | 25 | |
| 17 | 1980 | 22 | |
| 18 | 1991 | 21 | |
| 19 | 1994 | 21 | |
| 20 | 1980 | 19 |
About Ann Beaumont
Ann Beaumont is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology, Oncology, Endocrinology, Diabetes and Metabolism and Physiology, having authored 40 papers that have together received 1.9k indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (23 papers), Peptidase Inhibition and Analysis (23 papers), Signaling Pathways in Disease (7 papers), Biochemical and Structural Characterization (6 papers), Diabetes Treatment and Management (6 papers), Receptor Mechanisms and Signaling (5 papers), Protease and Inhibitor Mechanisms (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (848 citations), Oncology (813 citations), Molecular Biology (956 citations), Physiology (322 citations) and Biotechnology (90 citations). Ann Beaumont has collaborated with scholars based in France, United Kingdom and Canada. Frequent co-authors include B P Roques, M C Fournié-Zaluski, Florence Noble, V. Daugé, Bernárd P. Roques, Joel W. Hughes, Michael O’Donohue, Cynthia Marie‐Claire, Philippe Crine and Hervé Le Moual. Their work appears in journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications, FEBS Letters, Molecular Pharmacology and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.